Influenza pandemics of 1918 and 2009: A comparative account

Future Virology

Volumn 8, Issue 4, 2013, Pages 335-342

  Khanna, Madhu ^a   Saxena, Latika ^a   Gupta, Ankit ^a   Kumar, Binod ^a   Rajput, Roopali ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

1918 H1N1 pandemic; 2009 H1N1 pandemic; influenza

Indexed keywords

HEMAGGLUTININ; OSELTAMIVIR; VIRUS VACCINE; ZANAMIVIR;

2009 H1N1 INFLUENZA; ANTIGENICITY; ANTIVIRAL THERAPY; CLINICAL FEATURE; COMPARATIVE STUDY; DRUG BIOAVAILABILITY; EXPERIMENTAL ANIMAL; HOST RANGE; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; MORTALITY; NONHUMAN; PATHOGENICITY; PHYLOGENY; PRIORITY JOURNAL; REVIEW; SEASONAL INFLUENZA; SEROLOGY; SPANISH INFLUENZA; VIRUS STRAIN;

AVES; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 84876134239     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.13.18     Document Type: Review

References (43)

1. Cox NJ, Subbarao K. Influenza. Lancet 354, 1277-1282 (1999).
2. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg/ Infect. Dis. 12(1), 15-21 (2006).
3. Reid AH, Fanning TG, Hultin JV et al. Origin and evolution of the 1918 'Spanish' influenza virus hemagglutinin gene. Proc. Natl Acad. Sci. USA 96, 1651-1656 (1999).
4. Guan Y, Vijaykrishna D, Bahl J et al. The emergence of pandemic influenza viruses. Protein Cell 1(1), 9-13 (2010).
5. Hsieh YH, Chan CH, Liu DP et al. Influenza pandemics: past, present and future. J. Formos. Med. Assoc. 105(1), 1-6 (2006).
6. Horimoto T and Kawaoka Y. Pandemic Threat posed by avian influenza A virus. Clin. Microbiol. Rev. 14(1), 129-149 (2001).
7. Reid AH, Fanning TG, Janczewski TA et al. Characterization of the 1918 'Spanish' influenza virus neuraminidase gene. Proc. Natl. Acad. USA 97(12), 6785-6790 (2000).
8. Kilbourne E D. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 12(1), 9-14 (2006).
9. Saglanmak N, Andreasen V, Simonsen L, Mølbak K, Miller MA, C Viboud. Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift. Vaccine 29S, B42-B48 (2011).
10. Chowell G, Viboud C, Simonsen L, Miller MA, Acuna-Soto R. Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations. J. Infect. Dis. 202(4), 567-575(2010).
11. Taubenberger JK. The origin and virulence of the 1918 'Spanish' influenza virus. Proc. Am. Philos. Soc. 150(1), 86-112 (2006).
12. Olson DR, Edelson LS, Morse SS. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc. Natl Acad. Sci. USA 102(31), 11059-11063 (2005).
13. Morens DM, Taubenberger JK, Harvey HA et al. The 1918 influenza pandemic: lessons for 2009 and the future. Crit. Care Med. 38(4), e10-e20 (2010).
14. Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325, 197-201 (2009).
15. Boëlle P-Y, Ansart S, Cori A et al. Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review. Influenza Other Respi. Viruses 5 (5), 306-316 (2011).
16. Reichert T, Chowell G, Nishiura H, Christensen RA, McCullers JA. Does glycosylation as a modifier of original antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect. Dis. 10(5) (2010).
17. Chowell G, Echevarría-Zuno S, Viboud C et al. Recrudescent wave of pandemic A/ H1N1 influenza in Mexico, winter 2011-2012: age shift and severity. PLoS Curr. 4, RRN1306 (2012).
18. Chowell G, Echevarría-Zuno S, Viboud C et al. Characterizing the epidemiology of the 2009 Influenza A/H1N1 Pandemic in Mexico. PLoS Med. 8(5), e1000436 (2011).
19. Tumpey TM, Basler CF, Aguilar PV et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310(5745), 77-80 (2005).
20. Terrence M. Tumpey, Taronna R. Maines, Neal Van Hoeven. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315 (5812), 655-659 (2007).
21. Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460 (7258), 1021-1025 (2009).
22. Kumar B, Khanna M, Kumar P et al. Quantification of viral load in clinical specimens collected from different body sites of patients infected with influenza viruses. Int. J. Med. Medical Sciences 3(5), 144-148 (2011).
23. Chowell G, Echevarria-Zuno S, Viboud C et al. Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico. PLoS ONE 7(7), e41069 (2012).
24. Gill JR, Sheng Z, Ely SF et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch. Pathol. Lab. Med. 134(2), 235-243 (2010).
25. CDC. Update: swine influenza A (H1N1) infections California and Texas. MMWR Morb. Mortal. Wkly Rep. 58, 1-3 (2009).
26. Khandaker G, Dierig A, Rashid H et al. Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza Other Respir. Viruses 5, 148-156 (2011).
27. Bal A, Suri V, Mishra B et al. Pathology and virology findings in cases of fatal influenza A H1N1 virus infection in 2009-2010. Histopathology 60, 326-335 (2012).
28. CDC. Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb. Mortal. Wkly Rep. 58, 536-541 (2009).
29. CDC. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb. Mortal. Wkly Rep. 58, 749-752 (2009).
30. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361(20), 1945-1952 (2009).
31. Garcia LG, Valdespino-Gómez JL, Lazcano Ponce E, Jimenez-Corona A. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 339, b3928 (2009).
32. Skowronski DM, De Serres G, Crowcroft NS et al. Association between the 2008-2009 Seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med. 7(4), e1000258 (2010).
33. Grasa S, Kedzierskia L, Valkenburgb SA et al. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc. Natl Acad. Sci. USA 107, 12599-12604 (2010).
34. Medina R A, Manicassamy B, Stertz S et al. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nature Comm. 1(3), 1-6 (2010).
35. Pearce MB, Belser JA, Gustin KM et al. Seasonal Trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets. J. Virol. 86(13) 7118-7125 (2012).
36. Igarashi M, Ito K, Yoshida R et al. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 5(1), e8553 (2010).
37. Xu R, Ekiert DC, Krause JC et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357-360 (2010).
38. Cohen J. What's old is new: 1918 virus matches H1N1 strain. Science 327(5973), 1563-1564 (2010).
39. Khanna M, Kumar B, Gupta N et al. Pandemic swine influenza virus (H1N1): a threatening evolution. Indian J. Microbiol. 49, 365-369 (2009).
40. Khanna M, Rajput R, Kumar P et al. Potent inhibition of pandemic influenza H1N1 (2009) virus propagation by novel chemically synthesized compounds. Influenza Other Respir. Viruses 5, 90-123 (2010).
41. WHO. 2010 pandemic (H1N1) 2009. Update 112. www.who.int/csr/disease/ swineflu/ transmission-zones/en
42. CDC. Vaccine virus selection for the 2012-2013 influenza season. www.cdc.gov/flu/about/season/vaccine-selection.htm
43. CDC. Seasonal influenza. Use of antivirals. www.cdc.gov/flu/ professionals/antivirals/ antiviral-use-influenza.htm